Showing results (1-10 of 624) with videos related to
Sort By:
Pageof 63
Bone Marrow Transplantation|September 26, 2001
Obesity and autologous stem cell transplantation in acute myeloid leukemiaG Meloni, A Proia, S Capria, et al.Haematologica|November 6, 2001
Thrombotic thrombocytopenic purpura: prospective neurologic, neuroimaging and neurophysiologic evaluationG Meloni, A Proia, G Antonini, et al.Leukemia|October 3, 2002
How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administrationG Meloni, S M Trisolini, S Capria, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Use of interleukin-2 in the management of haematological malignancies: focus on minimal residual diseaseF Mandelli, S Capria, M Vignetti, et al.Bone Marrow Transplantation|December 7, 2000
High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility studyG Meloni, S Capria, S Trasarti, et al.Haematologica|August 27, 1998
Chronic lymphocytic leukemia: from palliative therapy to curative intentG Meloni, F R Mauro, A Proia, et al.Leukemia & Lymphoma|May 1, 1996
Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 casesG Meloni, M Vignetti, C Andrizzi, et al.Bone Marrow Transplantation|October 1, 1996
BAVC regimen and autograft for acute myelogenous leukemia in second complete remissionG Meloni, M Vignetti, G Avvisati, et al.Annals of Hematology|April 6, 2004
Neutropenic enterocolitis in acute leukemia: diagnostic and therapeutic dilemmaS Capria, D Vitolo, C Cartoni, et al.Leukemia & Lymphoma|September 1, 1996
Autologous bone marrow transplantation in 44 patients with aggressive non-Hodgkin's lymphoma at University "La Sapienza" of RomeS Capria, M Vignetti, A Proia, et al.Pageof 63